Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazole

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 2, 2001, Pages 605-607

  Espinel Ingroff, A ^a  

^a Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ITRACONAZOLE; POSACONAZOLE; RAVUCONAZOLE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS; CONCENTRATION RESPONSE; DILUTION; FUNGICIDAL ACTIVITY; GERMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; ASPERGILLUS; CANDIDA; MICROBIAL SENSITIVITY TESTS;

EID: 0035141724     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.2.605-607.2001     Document Type: Article

References (25)

1. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents
2. Standardization of a hyphal inoculum of aspergilli for amphotericin B susceptibility testing
3. The in vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species
4. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy of invasive aspergillosis
5. Early experience with itraconazole in vitro and in patients: Pharmacokinetic studies and clinical results
6. Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi
7. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi
8. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
9. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743, 872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts
10. In vitro activity of a new oral triazole, BMS-207147 (ER-30346)
11. Amphotericin A and B, antifungal antibiotics produced by a streptomycete. I. In vitro studies
12. Antimycotic susceptibility testing of dermatoophytes in microcultures with a standardized fragmented mycelial inoculum
13. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi
14. Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide assay
15. In vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi
16. Antimicrobial susceptibility testing of six clinical isolates of Aspergillus
17. A propos des discordances observees dans los resultats des les resultats des CMI faites sur spores ou filaments d'Aspergillus
18. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents
19. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed standard M38-P
20. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.
21. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models
22. Incidence de l'ensemencement sur les resultats de l'antibiogramme antifongique des champiognons filamenteux du genre Aspergillus
23. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole
24. Invasive aspergillosis caused by Aspergillus ustus: Case report and review
25. Resistance to various inhibitors in Aspergillus nidulans